MDxHealth Shareholder Transparency Declarations
22 Novembro 2021 - 7:00PM
NEWS RELEASE – REGULATED INFORMATION
22 November
2021,
11:00
p.m. CET
MDxHealth
Shareholder Transparency
Declarations
IRVINE, CA, and
HERSTAL, BELGIUM – 22 November
2021 – MDxHealth SA (Nasdaq and Euronext Brussels: MDXH) (the
"Company" or "MDxHealth"), a
commercial-stage precision diagnostics company, announces today in
accordance with Article 14 of the Belgian Act of 2 May 2007 on the
disclosure of important participations in issuers of which shares
are admitted to trading on a regulated market and regarding
miscellaneous provisions (the "Belgian Transparency
Act"), that it received the following notifications.
MDxHealth was notified that the number of shares
with respect to which Soleus Capital Management, L.P. can exercise
voting rights actively crossed below the threshold of 3% of the
outstanding shares and voting rights of MDxHealth on 16 November
2021. Notably, it follows from the notification that the previously
reported shares of MDxHealth were held through Soleus Capital
Master Fund, L.P., a limited partnership formed in the Cayman
Islands. The notification also stated that the voting rights
attached to the shares were exercised by the investment advisor
Soleus Capital Management, L.P., a Delaware limited partnership, at
its discretion, in the absence of specific instructions, that
Soleus Capital Management, L.P. is controlled by a sole general
partner, Soleus GP, LLC, a Delaware limited liability company, and
that Soleus GP, LLC is controlled by its sole member, Mr. Guy
Levy.
MDxHealth was notified that the number of shares
with respect to which Bleichroeder LP can exercise voting rights
actively crossed above the threshold of 15% of the outstanding
shares and voting rights of MDxHealth on 19 November 2021. Notably,
it follows from the notification that an aggregate of 23,783,330
shares of MDxHealth, representing 15.25% of the 155,969,226
outstanding shares and voting rights of MDxHealth, is held through
the following entities: 21 April Fund LP (5,824,498 shares), 21
April Fund LTD (15,042,162 shares), Hill Family Alternative
Investments LLC (2,500,000 shares), and White Clover SA (416,670
shares) (the "Funds"). The notification also
stated that the voting rights attached to the shares are exercised
on behalf of the Funds by the investment adviser Bleichroeder LP, a
Delaware limited partnership, at its discretion, in the absence of
specific instructions, that Bleichroeder Holdings LLC, a Delaware
limited liability company, is the general partner of Bleichroeder
LP, that, as the general partner, Bleichroeder Holdings LLC holds
control over voting rights of Bleichroeder LP, and that
Bleichroeder Holdings LLC is not a controlled entity.
For further information, reference is made to
the information published on MDxHealth's website
(http://www.mdxhealth.com/investors/shareholder-information).
Pursuant to the Belgian Transparency Act and the
articles of association of the Company, a notification to the
Company and the Belgian Financial Services and Markets Authority
(FSMA) is required by all natural and legal persons in each case
where the percentage of voting rights attached to the securities
held by such persons in the Company reaches, exceeds or falls below
the threshold of 3%, 5%, 10%, and every subsequent multiple of 5%,
of the total number of voting rights in the Company.
About MDxHealth®MDxHealth is a
commercial-stage precision diagnostics company that provides
actionable molecular diagnostic information to personalize the
diagnosis and treatment of cancer. The Company's tests are based on
proprietary genetic, epigenetic (methylation) and other molecular
technologies and assist physicians with the diagnosis of urologic
cancers and prognosis of recurrence risk. The Company's European
headquarters are in Herstal, Belgium, with laboratory operations in
Nijmegen, The Netherlands, and U.S. headquarters and laboratory
operations based in Irvine, California. For more information, visit
mdxhealth.com and follow us on social media at:
twitter.com/mdxhealth, facebook.com/mdxhealth and
linkedin.com/company/mdxhealth.
For more information: |
|
MDxHealth |
|
info@mdxhealth.com |
|
|
|
|
|
Important information
The MDxHealth logo, MDxHealth, ConfirmMDx and
SelectMDx are trademarks or registered trademarks of MDxHealth SA.
All other trademarks and service marks are the property of their
respective owners.
- Transparency Press Release - Soleus and Bleichroeder (ENG)
MDxHealth (EU:MDXH)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
MDxHealth (EU:MDXH)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024